No
No
38
Total Publications
4
Abstract/Manuscript
5
Oral Presentation
29
Poster Presentation
2026 · Poster Presentation · Amgen · Dermatology
Machine learning–based identification of moderate-to-severe atopic dermatitis in US patients using the TARGET-DERM AD registry
Read more →2026 · Poster Presentation · Dermatology
A comparison of stable vs progressive hidradenitis suppurativa: insights from TARGET-DERM HS
Read more →2026 · Poster Presentation · Dermatology
The impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
Read more →2026 · Poster Presentation · Amgen · Dermatology
Real world characteristics and burden of patients initiating advanced systemic therapy in the TARGET-DERM atopic dermatitis registry
Read more →2026 · Poster Presentation · AbbVie · Gastroenterology
Characterization and Impact of Risankizumab on patients with Fistulizing Crohn’s Disease in the Real World: Findings from TARGET-GASTRO
Read more →2026 · Poster Presentation · AbbVie · Gastroenterology
Characterization and Impact of Upadacitinib on patients with Fistulizing Crohn’s Disease in the Real World: Findings from TARGET-GASTRO
Read more →2026 · Poster Presentation · Merck · Gastroenterology
Impact Of Early Endoscopic Remission After Advanced Therapy On Long-Term Complications In Crohn's Disease: Findings From TARGET-IBD
Read more →2026 · Poster Presentation · Merck · Gastroenterology
Impact Of Early Endoscopic Remission After Advanced Therapy On Long-Term Complications In Ulcerative Colitis: Findings From TARGET-IBD
Read more →2024 · Abstract/Manuscript · Northwestern University
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry
Read more →2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill
Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer
Read more →2021 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi
Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019
Read more →2020 · Poster Presentation · Novartis · Hepatology
Predicting advanced fibrosis using non-invasive clinical tests and modern machine learning methods in TARGET-NASH
Read more →2020 · Abstract/Manuscript · University of Michigan
Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease
Read more →2020 · Abstract/Manuscript · University of Michigan
Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases
Read more →2020 · Poster Presentation · Atrium Health · Gastroenterology
Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ECCO)
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Routinely Available Noninvasive Tests Perform Well in Identifying Patients with Advanced Fibrosis Due to NASH: Data from the TARGET-NASH Observational Cohort
Read more →2019 · Poster Presentation · Emory · Hepatology
Patient Reported Outcomes Among Pediatric Patients with Nonalcoholic Fatty Liver Disease: TARGET-NASH
Read more →2019 · Poster Presentation · Emory · Hepatology
Patterns of Medication Use Among Adult Patients with Elevated Serum ALT Levels in Patients with NAFLD: TARGET-NASH
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
The Prescribing Patterns and Use of Statins in Patients with Nonalcoholic Fatty Liver Disease
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Opioid use in patients with NAFLD: prevalence and association with comorbidities and disease severity
Read more →2019 · Poster Presentation · University of Michigan · Hepatology
Lean NAFLD patients have lower prevalence of cardiovascular, metabolic and severe liver disease compared to overweight or obese patients with NAFLD
Read more →2019 · Poster Presentation · University of Miami (FL) · Hepatology
Primary biliary cholangitis (PBC)-autoimmune hepatitis (AIH) overlap syndrome: Characteristics and response to obeticholic acid (OCA) in TARGET-PBC, a diverse, large United States (US) real-world cohort (DDW 2019)
Read more →2019 · Poster Presentation · University of Miami (FL) · Hepatology
Change in Lipids: Characteristics and Response to Obeticholic Acid (OCA) in TARGET-PBC, a Diverse, Large United States (US) Real-world Cohort (DDW 2019)
Read more →2019 · Poster Presentation · Saint Louis University · Hepatology
Management of Hepatocellular Carcinoma (HCC) in a Real Life Multinational, Longitudinal, Observational Study (TARGET-HCC)
Read more →2019 · Poster Presentation · Saint Louis University · Hepatology
Regional, racial/ethnic, and socioeconomic disparities and treatment outcomes in patients with hepatocellular carcinoma (HCC) in the US
Read more →2019 · Poster Presentation · Zucker School of Medicine at Hofstra · Hepatology
Effectiveness of Tenofovir Alafenamide in Patients with Chronic Hepatitis B Treated in Usual Clinical Practice: Results from the TARGET-HBV Observational Cohort Study (AASLD)
Read more →2019 · Poster Presentation · Atrium Health · Gastroenterology
Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ACG)
Read more →2019 · Oral Presentation · Hepatology
Incidence of Achieving Weight Loss Goals in Usual Clinical Practice: Results for the TARGET-NASH Observational Cohort
Read more →2019 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi
Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines
Read more →2018 · Poster Presentation · Emory · Hepatology
Characterization of polypharmacy in patients with NAFLD
Read more →2018 · Poster Presentation · Columbia University Medical Center · Hepatology
Clinical Profile of Adults with Nonalcoholic Steatohepatitis (NASH) with and without Type 2 Diabetes Mellitus (T2DM)
Read more →2018 · Poster Presentation · University of Michigan · Hepatology
Nonalcoholic Fatty Liver Disease in Children in the U.S.: Clinical Characteristics of Participants Enrolled in TARGET-NASH
Read more →2018 · Poster Presentation · University of Michigan · Hepatology
Real World Evidence Showing High Rates of Cardiovascular Events in NAFLD Patients Regardless of Liver Disease (DDW)
Read more →2018 · Poster Presentation · University of Texas Southwestern · Hepatology
Patient-Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC)
Read more →2018 · Poster Presentation · Atrium Health · Gastroenterology
Development of a Novel Longitudinal Observational Cohort of Adult and Pediatric Patients with Inflammatory Bowel Disease: TARGET-IBD
Read more →2018 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi
Real-world patterns of romiplostim treatment in adults with primary immune thrombocytopenia in the United States
Read more →2017 · Poster Presentation · University of Michigan · Hepatology
Sustained Elevation in Alkaline Phosphatase is Associated with Greater Disease Severity in Real World NAFLD in TARGET-NASH
Read more →2017 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi